We are excited to announce that Precision Antibody is a silver sponsor of the upcoming ImmunoBioseries 2024 West Coast Edition, happening on February 8-9th in sunny San Diego. This event marks a pivotal gathering for professionals in the immunotherapy and biomarker communities, showcasing the latest advancements and discussions in the field.
Precision Antibody’s Exhibit and Featured Talk
As part of our ongoing commitment to advancing research and development in antibody services, Precision Antibody will not only exhibit at the conference but will also have a prominent voice in the event’s proceedings. Our CEO, Dr. Ginette Serrero, an internationally recognized figure in the antibody development industry with extensive experience and numerous contributions to the field, will be one of the featured speakers.
Dr. Ginette Serrero’s Insightful Presentation
Dr. Serrero’s presentation is scheduled for the first day of the conference, February 8th, and is titled “Identification of Cancer Cell Surface Target for Antibody Drug Conjugate Development.” This talk will delve into the cutting-edge methodologies and innovative strategies Precision Antibody employs to identify viable cancer cell targets, a critical step in the development of effective antibody-drug conjugates (ADCs). ADCs represent a transformative approach in cancer therapy, offering targeted treatment options that minimize harm to healthy cells while effectively combating cancerous growths. She will also cover topics of companion diagnostics identification during therapeutic development for which she is an expert.
A Glimpse into the Future of Cancer Treatment
Attendees will gain valuable insights into the challenges and solutions associated with identifying suitable targets for ADCs, an area of research that holds great promise for the future of oncology and the field of biomarker and companion diagnostics. Dr. Serrero’s expertise and the work of Precision Antibody in this domain are at the forefront of making targeted cancer treatments more effective, personalized, and accessible.
Why You Should Attend
The 9th Biomarker and Companion Diagnostic track along with the Next-gen Immuno-Oncology Conference of the ImmunoBioseries meeting are a must-attend for anyone involved in or interested in the latest developments in immunotherapy and biomarker research. It’s a unique opportunity to network with industry leaders, scientists, and professionals who are shaping the future of personalized medicine.
For more details about the event and to view the full agenda, please visit the official event page: ImmunoBio Series West Coast Edition 2024.
Stay Connected
We invite you to join us at this remarkable event to learn more about the latest trends and innovations in antibody development and cancer treatment. Follow Precision Antibody’s journey at the ImmunoBioseries 2024 West Coast Edition on our social media channels for live updates and insights from the conference floor.
We look forward to seeing you in San Diego and together advancing the frontier of cancer treatment!
